{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:25:38Z","timestamp":1791897938940,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.braindev.2025.104454","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:19:54Z","timestamp":1758773994000},"page":"104454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and safety of risperidone and aripiprazole in reducing severity of irritability in children with autism spectrum disorder: A randomized controlled trial"],"prefix":"10.1016","volume":"47","author":[{"given":"Prateek Kumar","family":"Panda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indar Kumar","family":"Sharawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diksha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achanya","family":"Palayullakandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suthiraj","family":"Sopanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarama","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2025.104454_bb0005","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s10803-011-1284-z","article-title":"Evidence-based behavioral interventions for repetitive behaviors in autism","volume":"42","author":"Boyd","year":"2012","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.braindev.2025.104454_bb0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jama.2022.23661","article-title":"Autism Spectrum disorder: a review","volume":"329","author":"Hirota","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.braindev.2025.104454_bb0015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4103\/IJPSYM.IJPSYM_272_17","article-title":"Comprehensive Management of Autism: current evidence","volume":"39","author":"Shenoy","year":"2017","journal-title":"Indian J Psychol Med"},{"key":"10.1016\/j.braindev.2025.104454_bb0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/09540261.2018.1458706","article-title":"An update on pharmacotherapy of autism spectrum disorder in children and adolescents","volume":"30","author":"Goel","year":"2018","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.braindev.2025.104454_bb0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5498\/wjp.v13.i6.262","article-title":"Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials","volume":"13","author":"Hellings","year":"2023","journal-title":"World J Psychiatry"},{"key":"10.1016\/j.braindev.2025.104454_bb0030","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1517\/14656566.8.11.1579","article-title":"The status of pharmacotherapy for autism spectrum disorders","volume":"8","author":"Myers","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.braindev.2025.104454_bb0035","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2025.104454_bb0040","article-title":"Aripiprazole for autism spectrum disorders (ASD)","volume":"2016","author":"Hirsch","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.braindev.2025.104454_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.rasd.2012.08.001","article-title":"Risperidone or aripiprazole in children and adolescents with autism and\/or intellectual disability: a Bayesian meta-analysis of efficacy and secondary effects","volume":"7","author":"Cohen","year":"2013","journal-title":"Res Autism Spectr Disord"},{"key":"10.1016\/j.braindev.2025.104454_bb0050","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/phar.2271","article-title":"Pharmacotherapy of autism Spectrum disorder: results from the randomized BAART clinical trial","volume":"39","author":"DeVane","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.braindev.2025.104454_bb0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10578-013-0390-x","article-title":"A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial","volume":"45","author":"Ghanizadeh","year":"2014","journal-title":"Child Psychiatry Hum Dev"},{"key":"10.1016\/j.braindev.2025.104454_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmjebm-2021-111804","article-title":"Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews","volume":"28","author":"Fieiras","year":"2023","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.braindev.2025.104454_bb0065","article-title":"Risperidone for autism spectrum disorder","volume":"2007","author":"Jesner","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.braindev.2025.104454_bb0070","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/ijnp\/pyac033","article-title":"Aripiprazole and risperidone present comparable long-term metabolic profiles: data from a pragmatic randomized controlled trial in drug-na\u00efve first-episode psychosis","volume":"25","author":"V\u00e1zquez-Bourgon","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.braindev.2025.104454_bb0075","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/schbul\/sbv125","article-title":"A randomized comparison of aripiprazole and risperidone for the acute treatment of first-episode schizophrenia and related disorders: 3-month outcomes","volume":"41","author":"Robinson","year":"2015","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.braindev.2025.104454_bb0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4103\/ijmr.ijmr_746_22","article-title":"World autism awareness day: reflections on the Indian context","volume":"155","author":"Tonge","year":"2022","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.braindev.2025.104454_bb0085","first-page":"336","article-title":"A narrative review of autism Spectrum disorder in the Indian context","volume":"19","author":"Srivastava","year":"2023","journal-title":"J Indian Assoc Child Adolesc Ment Health"},{"key":"10.1016\/j.braindev.2025.104454_bb0090","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00127-019-01674-1","article-title":"DSM-5 criteria for autism spectrum disorder maximizes diagnostic sensitivity and specificity in preschool children","volume":"54","author":"Wiggins","year":"2019","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.braindev.2025.104454_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02206994","article-title":"The aberrant behavior checklist with children and adolescents with dual diagnosis","volume":"21","author":"Rojahn","year":"1991","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.braindev.2025.104454_bb0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2217\/phe.10.45","article-title":"Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6\u201317 years","volume":"4","author":"Blankenship","year":"2010","journal-title":"Pediatr Health"},{"key":"10.1016\/j.braindev.2025.104454_bb0105","first-page":"1","article-title":"Malin\u2019s intelligence scale for Indian children (MISIC): the erroneous practice of 6% proration","volume":"11","author":"Roopesh","year":"2021","journal-title":"Indian J Appl Res"},{"key":"10.1016\/j.braindev.2025.104454_bb0110","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/sleep\/23.8.1d","article-title":"The children\u2019s sleep habits questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children","volume":"23","author":"Owens","year":"2000","journal-title":"Sleep"},{"key":"10.1016\/j.braindev.2025.104454_bb0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1023\/A:1022602400621","article-title":"The revised Conners\u2019 parent rating scale (CPRS-R): factor structure, reliability, and criterion validity","volume":"26","author":"Conners","year":"1998","journal-title":"J Abnorm Child Psychol"},{"key":"10.1016\/j.braindev.2025.104454_bb0120","first-page":"45","article-title":"A validation study of the CARS-2 compared with the ADOS-2 in the diagnosis of autism Spectrum disorder: a suggestion for cutoff scores","volume":"34","author":"Ji","year":"2023","journal-title":"Soa Chongsonyon Chongsin Uihak"},{"key":"10.1016\/j.braindev.2025.104454_bb0125","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/sim.2300","article-title":"Properties of R(2) statistics for logistic regression","volume":"25","author":"Hu","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.braindev.2025.104454_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/cap.2009.0022","article-title":"Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability","volume":"20","author":"Arnold","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.braindev.2025.104454_bb0135","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.1097\/DBP.0000000000001219","article-title":"Complex autism Spectrum disorder: structural determinants of health and their impact on the diagnosis","volume":"44","author":"Canale","year":"2023","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.braindev.2025.104454_bb0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40272-016-0183-3","article-title":"Head-to-head comparison of aripiprazole and risperidone in the treatment of ADHD symptoms in children with autistic Spectrum disorder and ADHD: a pilot, open-label","volume":"18","author":"Lamberti","year":"2016","journal-title":"Randomized Controlled Study Pediatr Drugs"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760425001366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760425001366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T08:00:21Z","timestamp":1764403221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760425001366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0387760425001366"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2025.104454","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of risperidone and aripiprazole in reducing severity of irritability in children with autism spectrum disorder: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2025.104454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104454"}}